0.7875
前日終値:
$0.7624
開ける:
$0.7473
24時間の取引高:
29,884
Relative Volume:
0.01
時価総額:
$14.33M
収益:
$174.80K
当期純損益:
$-8.85M
株価収益率:
-1.1435
EPS:
-0.6887
ネットキャッシュフロー:
$-4.37M
1週間 パフォーマンス:
+39.62%
1か月 パフォーマンス:
-19.68%
6か月 パフォーマンス:
-17.99%
1年 パフォーマンス:
-75.58%
Nexalin Technology Inc Stock (NXL) Company Profile
NXL を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
|
NXL
Nexalin Technology Inc
|
0.7683 | 14.22M | 174.80K | -8.85M | -4.37M | -0.6887 |
|
ABT
Abbott Laboratories
|
126.88 | 222.19B | 43.84B | 13.90B | 6.92B | 7.9725 |
|
BSX
Boston Scientific Corp
|
98.52 | 144.97B | 19.35B | 2.78B | 3.82B | 1.8696 |
|
SYK
Stryker Corp
|
365.05 | 140.12B | 24.38B | 2.94B | 4.07B | 7.6159 |
|
MDT
Medtronic Plc
|
100.58 | 128.60B | 34.76B | 4.79B | 5.21B | 3.7017 |
|
EW
Edwards Lifesciences Corp
|
84.63 | 49.82B | 5.88B | 1.34B | 799.60M | 2.3489 |
Nexalin Technology Inc (NXL) 最新ニュース
Is Nexalin Technology Inc a good long term investmentFibonacci Retracement Levels & Free Technical Analysis and Insights - earlytimes.in
Nexalin Technology announces effective registration statement - MSN
Returns Recap: Why Nexalin Technology Inc stock remains resilientDay Trade & Verified High Yield Trade Plans - moha.gov.vn
Can Nexalin Technology Inc. Equity Warrant stock deliver strong Q4 earnings2025 Trading Recap & Daily Oversold Stock Bounce Ideas - Улправда
Nexalin Technology and BioVie Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV - Daily Commercial
Why retail investors favor Nexalin Technology Inc. Equity Warrant stock2025 Trading Recap & Free Community Supported Trade Ideas - Улправда
Will Nexalin Technology Inc. stock outperform value stocksEarnings Trend Report & Low Risk High Win Rate Picks - Улправда
How Nexalin Technology Inc. Equity Warrant stock performs after earnings2025 Price Momentum & Weekly High Momentum Picks - Улправда
Is Nexalin Technology Inc. Equity Warrant stock a safe haven assetQuarterly Market Summary & Risk Adjusted Buy/Sell Alerts - ulpravda.ru
Fed Watch: Is Nexalin Technology Inc. stock supported by innovation pipeline2025 Price Momentum & Technical Confirmation Trade Alerts - Улправда
Is Nexalin Technology Inc. Equity Warrant stock in correction or buying zoneProduct Launch & Verified Momentum Stock Watchlist - Улправда
Why Nexalin Technology Inc. stock attracts high net worth investorsMarket Sentiment Summary & Risk Controlled Stock Alerts - DonanımHaber
Why Nexalin Technology Inc. stock could be next big winner2025 Price Momentum & Free Real-Time Volume Trigger Notifications - DonanımHaber
Is Nexalin Technology Inc. stock a dividend growth opportunityWeekly Gains Summary & Verified Entry Point Detection - Улправда
Will Nexalin Technology Inc. Equity Warrant stock deliver consistent dividendsMarket Growth Review & Stock Timing and Entry Methods - DonanımHaber
Is Nexalin Technology Inc. stock supported by innovation pipelineJuly 2025 Big Picture & Daily Technical Stock Forecast Reports - Улправда
Can Nexalin Technology Inc. Equity Warrant stock beat market expectations this quarter2025 Key Highlights & Expert Approved Trade Ideas - DonanımHaber
Will Nexalin Technology Inc. stock maintain growth storyTrade Risk Assessment & Safe Entry Point Alerts - Улправда
VIX Spike: Is Nexalin Technology Inc. Equity Warrant stock a safe haven assetJuly 2025 Macro Moves & Free Community Consensus Stock Picks - Улправда
Why Nexalin Technology Inc. stock is favored by pension fundsJuly 2025 Drop Watch & Technical Entry and Exit Alerts - Улправда
RSI Check: Will Nexalin Technology Inc. stock maintain growth storyJuly 2025 Pullbacks & Smart Money Movement Alerts - Улправда
Nexalin Technology (NASDAQ:NXL) Shares Down 10.9% – Time to Sell? - Defense World
What analysts say about Nexalin Technology Inc Equity Warrant stockEarnings Miss Alerts & Superior Capital Trading Plans - earlytimes.in
Market Overview: Will Nexalin Technology Inc stock outperform value stocksTrade Entry Report & Low Risk Investment Opportunities - moha.gov.vn
Nexalin Technology Stock Drop Looks Sharp, But How Deep Can It Go? - Trefis
Nexalin Technology unveils new investor presentation on DIFS - MSN
Nexalin Technology Unveils New Investor Presentation on DIFS - TipRanks
Nexalin Technology, Inc. Unveils Advanced Neurostimulation Technology - TradingView — Track All Markets
Will Nexalin Technology Inc. Equity Warrant stock reach Wall Street targetsTreasury Yields & Real-Time Stock Entry Alerts - Newser
Nexalin advances Alzheimer’s device after FDA meeting By Investing.com - Investing.com South Africa
Nexalin Technology completes FDA Q-submission meeting for Gen-2 Sync - marketscreener.com
Nexalin advances Alzheimer’s device after FDA meeting - Investing.com
Nexalin Technology Completes FDA Q-Submission Meeting for - GlobeNewswire
Nexalin Technology Completes FDA Q-Submission Meeting for Gen-2 SYNC™ Neurostimulation Console in Alzheimer’s Disease Program - Sahm
Join Nexalin Technology’s Exclusive Live Investor Webinar and Q&A Session on December 4 - markets.businessinsider.com
How Nexalin Technology Inc. stock trades before earnings2025 Trading Recap & Risk Controlled Stock Alerts - Newser
Nexalin Technology earnings missed by $0.01, revenue fell short of estimates - Investing.com Canada
12 Health Care Stocks Moving In Tuesday's Pre-Market Session - Benzinga
Volume Summary: Is Nexalin Technology Inc. Equity Warrant stock supported by strong cash flows2025 Technical Patterns & Smart Swing Trading Alerts - BỘ NỘI VỤ
Investors in cash trouble should check out Nexalin Technology Inc (NXL) - Setenews
Nexalin Technology (NASDAQ:NXL) Rating Lowered to Sell at Wall Street Zen - Defense World
Nexalin Technology Inc. (NXL) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
Is Nexalin Technology Inc. Equity Warrant stock near bottom after decline2025 Trade Ideas & Reliable Intraday Trade Plans - newser.com
Why hedge funds are buying Nexalin Technology Inc. stockEarnings Growth Report & Expert-Curated Trade Recommendations - newser.com
Price momentum metrics for Nexalin Technology Inc. explainedWeekly Market Report & Expert Curated Trade Setup Alerts - newser.com
Is Nexalin Technology Inc. Equity Warrant stock trading near support levelsEarnings Miss & Short-Term High Return Strategies - newser.com
Can Nexalin Technology Inc. stock withstand economic slowdown - newser.com
Nexalin Technology Inc (NXL) 財務データ
収益
当期純利益
現金流量
EPS
Nexalin Technology Inc (NXL) インサイダートレーディング
| インサイダートレーディング | 関係 | 日付 | 取引 | コスト | #株式 | 値 ($) | #株式総数 |
|---|---|---|---|---|---|---|---|
| Shelton Carolyn Hamby | Sr. VP - Quality, Regulatory |
Mar 12 '25 |
Buy |
2.20 |
6,000 |
13,200 |
30,000 |
| Owens David | Chief Medical Officer |
Feb 04 '25 |
Buy |
3.10 |
1,000 |
3,100 |
155,793 |
| Owens David | Chief Medical Officer |
Feb 04 '25 |
Buy |
2.98 |
1,000 |
2,980 |
154,793 |
| Owens David | Chief Medical Officer |
Jan 28 '25 |
Buy |
2.70 |
1,500 |
4,050 |
153,793 |
| Owens David | Chief Medical Officer |
Jan 13 '25 |
Buy |
2.50 |
2,000 |
5,000 |
151,293 |
| Owens David | Chief Medical Officer |
Jan 23 '25 |
Buy |
2.70 |
1,000 |
2,700 |
152,293 |
大文字化:
|
ボリューム (24 時間):